Arteris (NASDAQ:AIP) Upgraded by Wall Street Zen to “Hold” Rating
by Scott Moore · The Cerbat GemWall Street Zen upgraded shares of Arteris (NASDAQ:AIP – Free Report) from a sell rating to a hold rating in a research report released on Monday morning.
AIP has been the topic of a number of other research reports. Rosenblatt Securities reiterated a “buy” rating and set a $14.00 target price on shares of Arteris in a research note on Wednesday, May 21st. TD Cowen increased their target price on Arteris from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $15.00.
Read Our Latest Research Report on Arteris
Arteris Stock Up 1.1%
AIP opened at $9.23 on Monday. Arteris has a 12-month low of $5.46 and a 12-month high of $14.29. The stock has a market cap of $393.66 million, a price-to-earnings ratio of -11.26 and a beta of 1.44. The business has a 50 day moving average of $9.46 and a 200-day moving average of $8.22.
Arteris (NASDAQ:AIP – Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.11). The company had revenue of $16.50 million for the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts expect that Arteris will post -0.73 earnings per share for the current year.
Insider Activity
In other news, CFO Nicholas B. Hawkins sold 3,660 shares of the business’s stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $8.69, for a total value of $31,805.40. Following the transaction, the chief financial officer owned 103,898 shares in the company, valued at $902,873.62. The trade was a 3.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Laurent R. Moll sold 8,129 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $8.74, for a total value of $71,047.46. Following the completion of the transaction, the chief operating officer owned 386,552 shares in the company, valued at $3,378,464.48. The trade was a 2.06% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 520,616 shares of company stock worth $6,068,463. Company insiders own 29.10% of the company’s stock.
Hedge Funds Weigh In On Arteris
Several institutional investors have recently bought and sold shares of AIP. Acadian Asset Management LLC lifted its stake in Arteris by 40.6% in the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after purchasing an additional 260,277 shares during the last quarter. AQR Capital Management LLC bought a new stake in Arteris during the 1st quarter valued at $1,621,000. Federated Hermes Inc. raised its holdings in Arteris by 97.2% during the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company’s stock valued at $2,260,000 after acquiring an additional 161,241 shares during the period. Franklin Resources Inc. raised its holdings in Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company’s stock valued at $15,602,000 after acquiring an additional 142,936 shares during the period. Finally, Next Century Growth Investors LLC raised its holdings in Arteris by 46.4% during the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company’s stock valued at $2,817,000 after acquiring an additional 129,143 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- Manufacturing Stocks Investing
- Biotech Breakouts: 3 Stocks With Massive Upside Potential
- Investing in Commodities: What Are They? How to Invest in Them
- Powering Up: A Buy Rating Signals GE Vernova’s AI Tailwinds
- 3 Best Fintech Stocks for a Portfolio Boost
- The Side of Rate Cuts Nobody Is Telling You About